ORCA BI
ORCA BI is a Microsoft software services business with ongoing requirements for the best permanent and contract professionals.
ORCA BI
Social Links:
Industry:
Service Industry Software
Founded:
2009-01-01
Address:
Donnybrook, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.orcabi.com
Total Employee:
11+
Status:
Active
Contact:
+353 (0) 1 443 3898
Technology used in webpage:
Google Analytics Google Analytics Classic Skype Me Skype Download
More informations about "ORCA BI"
Who We Are - Orca Bio
Read Ivan's bio Ivan launched Orca Bio in 2016 and is Chief Executive Officer of Orca Bio. He is also cofounder and former Chief Technology Officer of Lucira Health, a molecular diagnostics company that received the first FDA โฆSee details»
Orca Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients. Orca Bio has developed a pipeline of proprietary technologies that have the potential to โฆSee details»
Orca Bio - LinkedIn
Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for the treatment of cancer and autoimmune diseases. Our investigational products are designed to safely ...See details»
Join Our Team - Orca Bio
Since our founding, Orca Bio's leadership team has delivered on its mission, swiftly advancing our investigational therapies from their foundational science into the clinicSee details»
Orca Bio Presents Positive Data Demonstrating the โฆ
Dec 9, 2023 The full ASH presentations will be made available on www.orcabio.com. About Orca-T Orca-T is an investigational high-precision allogeneic cell therapy being evaluated in clinical trials for the ...See details»
Orca Bio Expands in Greater Sacramento Building New State-of โฆ
Sep 8, 2022 โ The 100,000-square-foot facility is located in Metro Air Park, Sacramento โ Orca Bio, a late-stage biotechnology company developing high-precision cell therapies for the โฆSee details»
Orca Bio Emerges With Nearly $300 Million to Transform โฆ
Jun 17, 2020 The financing will support the continued advancement of Orca Bioโs cell therapy pipeline and its novel manufacturing platform, which sorts blood with single-cell precision and โฆSee details»
Orca Bio to Present Positive Clinical Outcomes with Orca-T in โฆ
MENLO PARK, Calif., May 23, 2024--Orca Bio, a biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced it will โฆSee details»
Orca Bio - Funding, Financials, Valuation & Investors - Crunchbase
Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients.See details»
Menlo Park, CA - orcabio.com
MENLO PARK, CA, November 5, 2024 โ Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today โฆSee details»
Orca Bio Expands in Greater Sacramento Building New
Sep 8, 2022 The organization spearheads community-led direction to retain, attract, grow and scale tradable sectors, develop advanced industries and create jobs and investment โฆSee details»
Orca Bio Receives Regenerative Medicine Advanced Therapy
MENLO PARK, Calif., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Orca Bio, a clinical-stage biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) โฆSee details»
Orca Bio to Present Positive Clinical Outcomes with Orca-T in โฆ
MENLO PARK, CA, May 23, 2024 โ Orca Bio, a biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced it will โฆSee details»
Orca Bio Presents Promising Data on Orca-T in Two Oral โฆ
Feb 23, 2024 MENLO PARK, Calif., February 23, 2024--Orca Bio, a late-stage biotechnology company developing high-precision cell therapies for the treatment of cancer, autoimmune โฆSee details»
Orca Bio Emerges With Nearly $300 Million to Transform
Jun 17, 2020 Company aims to safely and effectively regenerate a healthy blood and immune system for patients with hematological malignancies, genetic diseases and...See details»
Positive Clinical Results from More than 100 Patients ... - Business โฆ
Dec 11, 2021 The full presentation is available on www.orcabio.com. About Orca-T Orca-T is an investigational high-precision allogeneic cellular therapy consisting of infusions containing โฆSee details»
Orca Bio Presents Positive Data Demonstrating the Potential for โฆ
Dec 9, 2023 MENLO PARK, Calif., December 09, 2023--Orca Bio announced positive new data presented at the 65th American Society of Hematology (ASH) Annual Meeting.See details»
Orca Bio to Present Positive Clinical Outcomes with Orca-T in โฆ
May 23, 2024 For more information, visit www.orcabio.com and follow Orca Bio on X: @OrcaBio. Contacts. Corporate Communications Kelsey Grossman [email protected]. Investor โฆSee details»
Press release - Orca Bio
Dec 9, 2023 The full ASH presentations will be made available on www.orcabio.com. About Orca-T. Orca-T is an investigational high-precision allogeneic cell therapy being evaluated in โฆSee details»